Association analysis revealed that this polymorphism was strongly associated with MPN (OR= 6.61, 95% CI = 3.23 - 13.5), especially with JAK2 V617F-positive MPN (OR = 10.9, 95% CI = 4.88 - 24.3). This evidence concerns the gene JAK2 and myeloproliferative neoplasm.